Honda Motor Co., Ltd. today announced its consolidated financial results for the fiscal third quarter ended December 31, 2025. Q3 Ended December 31, 2025 Financial Results — Operating Profit 591.5 bil. yen — In motorcycle business, sales remained solid, primarily due to India and Brazil. — In automobile business, the impact of tariffs as well […]

(NYSE MKT:NSRX), TEL AVIV, Israel, Feb. 10, 2026 (GLOBE NEWSWIRE) — Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that it has entered into a securities purchase agreement (the “Agreement”) with certain institutional and accredited investors for a private

Nasus Pharma Announces Pricing of $15.0 Million Private Placement GlobeNewswire February 11, 2026 TEL AVIV, Israel, Feb. 10, 2026 (GLOBE NEWSWIRE) — Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that it has entered into a securities purchase agreement

In an era of noise, Light Stone Jewellery articulates a new dialect of quiet luxury through the silence of its forms. Unveiling a portfolio that functions as a “Wearable Culture Map,” the brand introduces a curatorial approach to designer jewellery, bridging the structural rigour of modern aesthetics with the profound resonance of Eastern antiquity. Light

(NASDAQ:GLTO), BOSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a biopharmaceutical company focused on developing novel therapeutics to redefine the treatment paradigm for people living with blood cancers, today announced the pricing of its previously announced underwritten public offering of shares of its common stock. Galecto is selling a total of 14,473,685

Galecto Announces Pricing of $275 Million Underwritten Public Offering GlobeNewswire February 11, 2026 BOSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a biopharmaceutical company focused on developing novel therapeutics to redefine the treatment paradigm for people living with blood cancers, today announced the pricing of its previously announced underwritten public offering of

(NYSE:CPNG), NEW YORK and NEW ORLEANS, Feb. 10, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Coupang, Inc. (“Coupang” or the “Company”) (NYSE: CPNG) of class action securities lawsuits. CLASS DEFINITION: The lawsuit seeks to recover losses on

Coupang, Inc. Notice of February 17, 2026 Application Deadline for Class Action Lawsuits – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline GlobeNewswire February 11, 2026 NEW YORK and NEW ORLEANS, Feb. 10, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of

(NYSE:KLAR), NEW YORK and NEW ORLEANS, Feb. 10, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Klarna Group plc (“Klarna” or the “Company”) (NYSE: KLAR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover

Klarna Group plc Notice of February 20, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline GlobeNewswire February 11, 2026 NEW YORK and NEW ORLEANS, Feb. 10, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General